Food and Drug Administration Commissioner Marty Makary said he plans to review the safety of abortion drug mifepristone after ...

The head of the Food and Drug Administration has vowed to conduct a review of the abortion pill as the drug continues to be ...

A recent study found that 11 percent of women experience an adverse effect from mifepristone, 22 times higher than its ...

The Chronicle spoke with Duke alumnus and professor Robert Califf about the recent “Make America Healthy Again” report and ...

FDA Commissioner Marty Makary committed to Sen. Josh Hawley that the agency will conduct a safety review of the abortion pill ...

The US Food and Drug Administration will meet its drug approval targets this year despite cutting thousands of staff, the ...

Nearly 1 in 5 positions across the Food and Drug Administration's human food inspection divisions are now vacant, multiple ...

June 4 (UPI) --Food and Drug Administration Commissioner Marty Makary said he plans to review the safety of abortion drug mifepristone after a recent study raised concerns about medical side effects.

Food and Drug Administration Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent to Senator Josh Hawley (R-Mo.).   “As with all drugs, FDA continues to ...

The U.S. Food and Drug Administration has rolled out a new AI assistant, Elsa, that it says will increase efficiency at its ...

The CDC, a $9.2 billion-a-year agency tasked with reviewing life-saving vaccines, monitoring diseases and watching for ...